Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
No Picture
News Feed

biOasis Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work with biOasis

September 4, 2014 The Wall Street Analyzer Comments Off on biOasis Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work with biOasis

SEPTEMBER 4, 2014 – BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF; TSXV:BTI), announces that the Natural Sciences and Engineering Research Council of Canada (“NSERC”) has awarded a grant to the University of British Columbia (“UBC”) in support of […]

No Picture
News Feed

biOasis Releases Quantitative Results: siRNA-Transcendpep reduces target gene expression in the brain

August 1, 2014 The Wall Street Analyzer Comments Off on biOasis Releases Quantitative Results: siRNA-Transcendpep reduces target gene expression in the brain

Thursday, July 25th, 2014 – BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF; TSX.V:BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB), announced on May 6th, 2014, that its […]